Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Asthma Control Rate Achieved by Budesonide/Formoterol in Clinical Practice in China

NCT01785901 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT01785901
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01785901 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Asthma Control Rate Achieved by Budesonide/Formoterol in Clinical Practice in China
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
May 31, 2013
Completion date
October 31, 2014
Enrollment
1,502 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

asthma